Holen Sie sich die Stockscreener-App
20.17
0.40%
-0.08
Schlusskurs vom Vortag:
$20.25
Offen:
$20.01
24-Stunden-Volumen:
4.80M
Relative Volume:
1.73
Marktkapitalisierung:
$5.03B
Einnahmen:
$724.83M
Nettoeinkommen (Verlust:
$182.33M
KGV:
26.53
EPS:
0.7602
Netto-Cashflow:
$338.84M
1W Leistung:
+5.99%
1M Leistung:
+3.92%
6M Leistung:
+8.85%
1J Leistung:
+20.92%
1-Tages-Spanne:
$19.67
$20.54
1-Wochen-Bereich:
$18.73
$20.54
52-Wochen-Spanne:
$15.60
$20.54
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Compare SBRA vs WELL, VTR, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBRA
Sabra Healthcare Reit Inc
|
20.17 | 5.05B | 724.83M | 182.33M | 338.84M | 0.7602 |
|
WELL
Welltower Inc
|
210.72 | 144.97B | 10.83B | 961.84M | 1.88B | -0.7091 |
|
VTR
Ventas Inc
|
85.24 | 40.47B | 5.83B | 261.52M | 1.32B | 0.5422 |
|
OHI
Omega Healthcare Investors Inc
|
47.40 | 13.90B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
16.70 | 11.32B | 2.80B | -10.95M | 1.15B | -0.0564 |
|
AHR
American Healthcare Reit Inc
|
51.80 | 9.21B | 2.07B | -37.81M | 84.15M | -0.27 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | UBS | Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-01-17 | Herabstufung | Truist | Buy → Hold |
| 2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Outperform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-27 | Eingeleitet | Berenberg | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-09-30 | Hochstufung | Truist | Hold → Buy |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-02-05 | Eingeleitet | Berenberg | Hold |
| 2019-12-20 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
| 2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Stifel | Hold |
| 2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
| 2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
Sabra Healthcare REIT Q1 2026 slides: Targeting 5% FFO growth with diversified portfolio - Investing.com Nigeria
Sabra Health Care REIT, Inc. (SBRA) Shares Steady as Managed Senior Housing Drives 2025 Growth - AlphaStreet News
Why Sabra Health Care REIT (SBRA) Is Up 5.6% After 2025 Results And 2026 Earnings Guidance - simplywall.st
Sabra Healthcare REIT Q4 Earnings Call Highlights - MarketBeat
Sabra Health Care REIT, Inc. to Attend Citi’s 2026 Global Property CEO Conference - Business Wire
Earnings call transcript: Sabra Healthcare REIT misses EPS forecast in Q4 2025 - Investing.com India
Sabra Health Care REIT, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
LSV Asset Management Trims Stake in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT stock hits 52-week high at 19.97 USD - Investing.com Canada
Sabra Healthcare REIT (NASDAQ:SBRA) Issues FY 2026 Earnings Guidance - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Sets New 52-Week HighTime to Buy? - MarketBeat
Sabra: Q4 Earnings Snapshot - kare11.com
Sabra Healthcare REIT (NASDAQ:SBRA) Releases Quarterly Earnings Results, Misses Expectations By $0.28 EPS - MarketBeat
Sabra: Fourth Quarter Financial Highlights - Bitget
Sabra Healthcare REIT Issues 2026 Outlook and Dividend - TipRanks
Sabra Healthcare REIT stock hits 52-week high at 19.97 USD By Investing.com - Investing.com South Africa
Sabra Healthcare earnings up next: Can REIT recover from Q3 miss? - Investing.com UK
Sabra Healthcare earnings up next: Can REIT recover from Q3 miss? By Investing.com - Investing.com Nigeria
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Allianz Asset Management GmbH Buys 81,293 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT announces executive leadership transition - MSN
Sabra Healthcare REIT (SBRA) Expected to Announce Earnings on Thursday - MarketBeat
Thrivent Financial for Lutherans Sells 115,983 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Plans Quarterly Dividend of $0.30 - MarketBeat
Sabra Health Care REIT Sets February 22, 2026, for Q4 Earnings Release and Declares $0.30 Dividend - geneonline.com
Sabra Health Care REIT, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call; Declares Common Dividend - Business Wire
Cornerstone Wealth Management LLC Purchases 28,625 Shares of Sabra Healthcare REIT, Inc. $SBRA - Defense World
Principal Financial Group Inc. Sells 474,618 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $2.77 Million Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by AlphaQuest LLC - MarketBeat
Sabra Health Care: A Compelling REIT Opportunity As SHOP Unlocks Hidden Value - Seeking Alpha
Is Sabra Health Care REIT (SBRA) Offering Value After Its Strong Three Year Share Price Gain - Yahoo Finance
Sabra Health Care REIT, Inc. Announces Tax Treatment of 2025 Distributions - Business Wire
Y Intercept Hong Kong Ltd Purchases Shares of 321,988 Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by SG Americas Securities LLC - MarketBeat
Truist Financial Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price - Defense World
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $21.00 at Truist Financial - MarketBeat
Tred Avon Family Wealth LLC Takes Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
Assessing Sabra Health Care REIT (SBRA) Valuation After Appointment Of New Chief Investment Officer - Sahm
UBS Remains a Hold on Sabra Healthcare REIT (SBRA) - The Globe and Mail
Sabra Healthcare REIT Announces Executive Leadership Transition - TipRanks
Does Sabra’s CIO Transition to Insider Darrin Smith Reshape the Bull Case for Sabra Health Care REIT (SBRA)? - simplywall.st
Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer - TechStock²
Sabra Health Care REIT names Darrin Smith as new chief investment officer By Investing.com - Investing.com Nigeria
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
2.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):